|Karel Allegaert received his MD and PhD at the KU Leuven, Belgium where he trained as a paediatrician-neonatologist, with an additional expertise in clinical pharmacology. He is professor at the KU Leuven (department of development and regeneration) and is clinical consultant at the paediatric and neonatal intensive care unit of the Sophia’s Children’s Hospital, Rotterdam, The Netherlands. His research is focused on developmental perinatal pharmacology and neonatal and paediatric pain, has been supported by European funding (Albino study), and national grants (FWO, IWT-SBO) and has resulted in about 300 PubMed citations, H index 34. He is member of the Royal Academy of Medicine of Belgium, president of the European Society of Developmental Pharmacology and former section head clinical pharmacology of the European Society of Pediatric Research.|
|Professor Marc Benninga studied medicine at the University of Amsterdam, the Netherlands. After receiving his Medical degree he worked as a research fellow at the department of paediatric gastroenterology and nutrition at the Academic Medical Centre in Amsterdam with Jan Taminiau and Hans Büller. He performed extensive research on constipation and faecal incontinence in childhood. Subsequently he was trained in paediatrics at the Wilhelmina Children’s Hospital in Utrecht, The Netherlands. After his paediatric training he performed research at The Women’s and Children’s Hospital, Adelaide, Australia with Geoff Davidson and Taher Omari. During his stay in Adelaide his research focussed on maturation of upper gastrointestinal motility in very young infants. In 1999 he became a staff member in the Academic Medical Centre in Amsterdam and currently he is the head of the department paediatric gastroenterology & Nutrition. The focus of his current clinical and research work is gastro-oesophageal reflux disease, recurrent abdominal pain, constipation, functional non-retentive faecal incontinence and inflammatory bowel disease in childhood. He played in the Dutch National hockey team and competed at the Olympics in 1988, Seoul.|
|Nick Bishop is the UK’s only Professor of Paediatric Bone Disease, at the University of Sheffield and Sheffield Children’s Hospital. His group’s clinical and research work focuses mainly on children with osteogenesis imperfecta, osteoporosis and inherited forms of rickets, as well as research into these conditions. He is Director of the Clinical Research Facility at Sheffield Children’s Hospital and Associate Director of the Arthritis Research UK-funded Experimental Arthritis Treatment Centre for Children, leading the Bone Health theme.|
|Frank Bloomfield is Director of the Liggins Institute and Professor of Neonatology at the University of Auckland in New Zealand. He trained in Manchester, Auckland and Toronto, taking his BSc (Hons) and MBChB from the University of Manchester and his PhD from the University of Auckland. Frank practises as a neonatologist at National Women’s Hospital in Auckland and leads a research group at the Liggins Institute investigating fetal and neonatal nutrition and its impact on long-term outcomes. He is a past president of the Perinatal Society of New Zealand and of the Perinatal Society of Australia and New Zealand and is a current council member of the Perinatal Research Society in the USA. Frank serves on New Zealand’s National Maternity Monitoring Group and the Clinical Governance Board of the NZ National Intestinal Failure Service.|
|James Boardman is Professor of Neonatal Medicine at the University of Edinburgh and Director of the Jennifer Brown Research Laboratory, situated in the MRC Centre for Reproductive Health. He uses neonatal quantitative MR imaging to investigate causal pathways to brain injury, the factors that confer risk or resilience to injury after perinatal adversity, and the relationship between quantitative MR features and long-term functional outcome.|
|Alan Boyd is a graduate in Biochemistry and Medicine from the University of Birmingham, and a Fellow and currently President of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He was previously Chair of the Specialist Advisory Committee in Pharmaceutical Medicine at The Royal College of Physicians. In November 2009 he was appointed an Honorary Professor at the College of Medical and Dental Sciences at the University of Birmingham Medical School, in recognition of his expertise in medicines development.In October 2014, he was elected as a fellow of the Royal Society of Biology. Alan also received the ‘Outstanding Contribution Award’ at the 15th Annual Bionow Awards ceremony in November 2016. This award was given in recognition of his significant contribution to the development of medicines and the speciality of Pharmaceutical Medicine as an industrialist, an educator and an inspirational leader.|
|Lucy Chappell is NIHR Research Professor in Obstetrics at King’s College London and Honorary Consultant Obstetrician at Guy’s and St Thomas’ NHS Foundation Trust. She runs a research programme investigating prediction and prevention of adverse pregnancy outcomes, particularly in women with pre-existing co-morbidities such as chronic hypertension and chronic kidney disease, using randomised controlled trials and observational studies. She has subspecialty training in maternal-fetal medicine and a Masters in higher education, supervising higher degree students from obstetric, nephrology and general practice backgrounds. She is an academic editor for PLoS Medicine journal, a member of the NIHR HTA Clinical Evaluation and Trials board, and a committee member for the Blair Bell Research Society, RCOG Maternal Medicine Clinical Studies Group, and the International Society for the Study of Hypertension in Pregnancy council.|
|Kate Costeloe was Professor of Paediatrics at Queen Mary University of London, and Honorary Consultant at Homerton University Hospital, London, UK. She has now retired. Her research interests have been focused on non-invasive physiological measurement and more recently on outcomes following extremely preterm birth, the prevention of necrotising enterocolitis and the development and harmonisation of population based neonatal databases. She was Principal Investigator for the Perinatal Component of the EPICure studies of population based outcomes and Chief Investigator for the PiPS multi-centre trial of the probiotic Bifidobacterium breve BBG-001 to prevent Necrotising Enterocolitis and sepsis following preterm birth.|
|Steve Cunningham is a Professor and Honorary Consultant of Paediatric Respiratory Medicine the University of Edinburgh and Royal Hospital for Sick Children, NHS Lothian. His research interests include acute viral bronchiolitis of infancy, asthma, rare lung disease and cystic fibrosis. In the area of bronchiolitis, Steve is the Chief Investigator for the multicenter HTA funded BIDS study, Chair of the NICE Bronchiolitis guideline and is International Coordinating Investigator for a novel Phase 1 product (Ablynx 0171) for the treatment of RSV and Principle Investigator for a second Phase 1 product (Alios 8176). In other interests, Steve is part of the core management team and UK Coordinator for European Rare Lung Disease projects (FP7 funded ChILDEU, ChILD COST, ERS CRC ChILD) and is active in small molecule therapeutic studies in young children with CF. Steve is also a member of the Asthma UK Centre for Applied Research supervising PhD students in asthma topics.|
|Linda de Vries trained as a pediatrician and neonatologist in the Wilhelmina Children’s Hospital in Utrecht, the Netherlands. Subsequently she also trained as a pediatric neurologist in Leuven, Belgium. Since 1989, she has worked in the department of Neonatology in Utrecht, where she is a professor in Neonatal Neurology since 2001. Her research focuses on prediction of neurodevelopmental outcome in high risk preterm and full-term newborns, using neurophysiology and neuro-imaging methods. These at risk children are also seen by her in the follow-up clinic. She has a special interest in neonatal stroke and brain plasticity. She is also an adjunct professor in neonatal neurology at University of California San Francisco (UCSF).|
|Allan Goldman trained as a doctor in South Africa before coming to London in 1990. He completed his paediatric intensive care specialisation in both London and Australia. He took up the post of consultant at Great Ormond Street Hospital (GOSH) in 1998. In 2003 he was appointed as Lead Consultant for the Cardiac Critical Care Unit and Director of the ECMO service at GOSH. He is currently Divisional Co-Chair and Divisional Director of the West Division.|
|Robert C Green is a medical geneticist and physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School.
Dr Green is principal investigator of the NIH-funded REVEAL Study, in which a cross-disciplinary team has conducted 4 separate multi-center randomized clinical trials since 2000. He also co-directs the NIH-funded PGen Study, one of the first prospective studies of direct-to-consumer genetic testing services. He is principal investigator of the MedSeq Project, the first NIH-funded randomized trial to explore the use of whole genome sequencing in the clinical practice of medicine and co-directs the BabySeq Project, the first NIH-funded trial of sequencing in newborns.
Dr Green is currently Associate Director for Research of the Partners Center for Personalized Genetic Medicine, a Board Member of the Council for Responsible Genetics and a member of the Informed Cohort Oversight Boards for both the Children’s Hospital Boston Gene Partnership Program and the Coriell Personalized Medicine Collaborative. He was the lead author of the recently published recommendations from the American College of Medical Genetics and Genomics for management of incidental findings in clinical sequencing.
|Jonathan Grigg is the leading UK paediatrician in the effects of air pollution. His research has identified the mechanisms whereby inhalation of particles increases vulnerability to bacterial infection. These studies have informed the public on the risks of air pollution, and influenced national policy. He was a lead author of the Royal College of Physicians’ Report on the long-term effects of air pollution. In the area of paediatric respiratory medicine, he has led major independent and industry trials of new and existing asthma therapies. He is the Deputy Director of the North Thames CLAHRC, and Director of the CLAHRC's Children and Adolescent’s Theme. Funded by the CLAHRC he has developed an online objective asthma control test, and using this in schools has found poor levels of asthma control.|
|Dominic King moved from Imperial College London to be Senior Clinician Scientist at Google DeepMind. He continues as an Honorary Clinical Lecturer in Surgery at Imperial College London, where his research interests had centred around behavioural economics and design, digital health and public health.|
|Berthold Koletzko is professor of Pediatrics and head of the Division of Metabolic and Nutritional Medicine at Hauner Children’s Hospital, University of Munich Medical Center, in Munich, Germany. Following work at paediatric departments in South Africa and Tanzania, he qualified in paediatrics at the Children’s Hospital, University of Düsseldorf, Germany. He worked as a post-doc in clinical nutrition and metabolism at the Hospital for Sick Children, University of Toronto, Canada.
Koletzko’s research focuses on metabolism and nutrition in childhood, pregnancy and lactation, metabolic diseases and clinical nutrition. He has co-authored more than 750 publications and received numerous awards and honours. He serves as coordinator of Collaborative Research Programmes, including the Early Nutrition Programming of Adult Health project, the Multidisciplinary Early Modification of Obesity Risk Project and the EU Research Network on Malnutrition and Outcome in Hospitalised Children.
|Dame Tina Lavender is Professor of Midwifery and Director of the Centre for Global Women’s Health at the University of Manchester. She also holds an honorary contract at St Mary’s Hospital, Manchester and a Visiting Professorship at the University of Nairobi. She leads a programme of research, Midwifery and Women's Health; her main research focus being the management of prolonged labour and partogram use. Dame Tina has published extensively in this field. She is Co-editor in Chief of the British Journal of Midwifery, Associate Editor of the African Journal of Midwifery and Women’s Health, Editor of the Pregnancy and Childbirth Group of the Cochrane Collaboration and on the editorial team of the British Journal of Obstetrics and Gynaecology. Dame Tina is an Honorary Fellow of the Royal College of Midwives and European Academy of Nurse Science. Dame Tina also acts as a regular Advisor to the World Health Organization, particularly in relation to guideline development.|
|Neena Modi is Professor of Neonatal Medicine at Imperial College London and President of the Royal College of Paediatrics and Child Health. She also has clinical duties as a Honorary Consultant in Neonatal Medicine at Chelsea and Westminster NHS Foundation Trust where she is the senior consultant in a team providing neonatal services for a tertiary referral service, and lead medical and surgical perinatal service for north-west London.|
|David Nott has been a Consultant Surgeon at Chelsea and Westminster Hospital for nearly 15 years. He is also specialised within vascular surgery and is an authority in laparoscopic surgery - in particular AAA repairs and distal arterial bypasses. He is the first surgeon to combine laparoscopic and vascular surgery.
In addition, Mr Nott spends a few months every year working for Médecins Sans Frontières and the British Red Cross performing surgery in areas such as Darfur/Afghanistan and Iraq.
|Niamh Nowlan’s research is in the biomechanics of fetal movements, with particular focus on the role of fetal movements in normal skeletal development, and the importance of fetal movements as a measure for fetal health. Prior to joining Imperial College in 2011, Dr Nowlan held two postdoctoral fellowships in Trinity College Dublin, Ireland and in the Centre for Genomic Research, Barcelona, Spain. In 2009, she travelled to the USA as a Fulbright scholar, and spent six months working in Boston University. Dr Nowlan obtained a PhD in Bioengineering from Trinity College Dublin, Ireland in 2007, and holds a degree in Computer Engineering.|
|Andy Oxman is a health services researcher in the Global Health Unit at the Norwegian Institute of Public Health. His research over the past three decades has focused on ways of helping people to make informed choices about healthcare. His current research focuses primarily on developing and evaluating learning resources to enable people to assess claims about effects. He is particularly interested in resources for children and for people in low-income countries.|
|Andrew Pollard is Professor of Paediatric Infection and Immunity at the University of Oxford, Director of the Oxford Vaccine Group, Fellow of St Cross College and Honorary Consultant Paediatrician at the Children’s Hospital, Oxford, UK. He chaired the UK’s National Institute for Health and Care Excellence (NICE) meningitis guidelines development group, and the NICE topic expert group developing quality standards for management of meningitis and meningococcal septicaemia. He chairs the UK Department of Health’s Joint Committee on Vaccination and Immunisation and the European Medicines Agency scientific advisory group on vaccines and is a member of WHO’s SAGE. His research includes the design, development and clinical evaluation of vaccines including those for meningococcal disease and enteric fever and leads studies using a human challenge model of (para)typhoid. He has a particular interest in the development of B cell immunity in early childhood. He runs surveillance for invasive bacterial diseases and studies the impact of pneumococcal vaccines in children in Nepal and leads a project on burden and transmission of typhoid in Nepal, Bangladesh and Malawi and co-leads typhoid vaccine impact studies at these sites. He has supervised 23 PhD students and his publications include over 300 manuscripts and books on various topics in paediatrics and infectious diseases. He made the first British ascents of Jaonli (6632m) and Chamlang (7309m), was the Deputy leader of the 1994 British Mount Everest Medical Expedition and is a member of the Alpine Club.|
|Rebecca Reynolds is Professor of Metabolic Medicine, University of Edinburgh and Honorary Consultant Physician in Diabetes & Endocrinology, NHS Lothian and Director of the Centre for Cardiovascular Sciences, University of Edinburgh. Her main research interest is in the early life origins of health and disease and she was awarded the Nick Hales Award by the International Society for the Developmental Origins of Health and Disease and the Curt Richter Award by the International Society of Psychoneuronendocrinology in recognition of this work. She is Chair of the Diabetes UK Clinical Studies Group ‘Causes of Diabetes’. Her work spans ‘process to population’ eg experimental medicine studies in pregnant women and their children, detailed mechanistic studies using placental tissue, randomised controlled trials testing interventions in pregnancy to improve outcomes and epidemiological data-linkage studies using ‘big data’ in Scotland.|
|Tina Slusher divides her time between the Pediatric Intensive Care Unit at Hennepin County Medical Center and patient care at missionary and academic hospitals in Nigeria and Kenya. Dr Slusher regularly lectures for medical trainees (nurses, med students, residents and fellows) and consultants in the U.S., Nigeria other African countries and Thailand. Courses and lectures she recently has taught: global health for students; neonatal resuscitation, including Helping Babies Breath; management of ventilators; neonatal care in low-resource settings; pain management; recognition and treatment of neonatal jaundice; treatment of malnutrition; and immunization updates.|
|Philip Steer is Professor Emeritus at Imperial College London, having been appointed Professor in 1989. He was a consultant obstetrician for 35 years, based at the Chelsea and Westminster Hospital from 1994. He has authored many research papers, reviews, editorials and book chapters/books. His particular interests are the pathophysiology of labour and the effects of maternal heart disease on pregnancy. He was Editor-in-Chief of BJOG – an International Journal of Obstetrics and Gynaecology - from 2005-2012, is now editor emeritus, and edits the ‘BJOG on the case’ series. He is currently an editor of ‘High Risk Pregnancy – Management Options’ with the fifth edition published by Cambridge University Press in 2017, who also in 2016 published the second edition of ‘Heart Disease in Pregnancy’ that he edits with Prof Michael Gatzoulis. He was President of the British Association of Perinatal Medicine from 1996 to 1999 and President of the Section of Obstetrics and Gynaecology of the Royal Society of Medicine from 2008 to 2009.|
|Eline van der Beek is Professor in Nutritional Programming at the University of Groningen. She was Research Director of Danone-Nutricia Early Life Nutrition in Singapore, the first centre in Asia to focus on maternal and child health, for 5 years. In August 2015 she returned to the Netherlands where she is now heads a Centre of Excellence in Metabolism and Growth. Eline continues to study nutritional programming of later life health understanding the contribution of the health of the mother as well as the role of nutrition, in particular nutrient quality during different stages of development. Eline is a (co)inventor of more than 25 patent applications and has published more than 80 articles in peer reviewed journals.|
|Yvonne Wagner specialises in paediatric dentistry, teaching for qualifications in academic studies and medication education, numerous international and national lectures and publications. Her research interest is in infant oral health.|
|Jennifer Zeitlin is a perinatal epidemiologist at Inserm, Paris. Her research focuses on assessing the impact of the organization of care on the health and development of babies born very preterm (< 32 weeks of gestational age) in France and other European countries and on the effects of the restructuring of obstetric and paediatric health services on access to care for pregnant women and newborns. She also leads a project to develop perinatal health surveillance for the evaluation of health systems and policy in Europe. These studies principally use epidemiological methods and include collaborations with geographers and health services researchers.|
This site is maintained by The Symposium Office. We never sell our database to third parties.
Content: © 2017 The Symposium Office Web design & technology: © 2017 elderberry